![Jürgen Reess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jürgen Reess
Direktör/Styrelseledamot på
CYXONE AB
Profil
Jürgen Reess is the founder of Mogling Bio.
He is currently the Director at Cyxone AB and the Chief Marketing Officer at SciRhom GmbH.
Previously, he worked as the Managing Director at Cellerys AG.
He holds a doctorate degree from Universität Ulm.
Aktiva positioner av Jürgen Reess
| Företag | Position | Start |
|---|---|---|
| CYXONE AB | Direktör/Styrelseledamot | 2023-01-01 |
Mogling Bio
 Mogling Bio BiotechnologyHealth Technology Operates as a biotechnology company | Verkställande Direktör | - |
SciRhom GmbH
 SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Försäljning & Marknadsföring | - |
Tidigare kända positioner av Jürgen Reess
| Företag | Position | Slut |
|---|---|---|
Cellerys AG
 Cellerys AG Miscellaneous Commercial ServicesCommercial Services Engages in conducting research on a therapy to fight multiple sclerosis | Verkställande Direktör | - |
Jürgen Reesss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
1
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Universität Ulm
 Universität Ulm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyxone AB
 Cyxone AB Pharmaceuticals: MajorHealth Technology Develops cyclotide drugs for autoimmune and other diseases | Health Technology |
SciRhom GmbH
SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Health Technology |
Mogling Bio
Mogling Bio BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cellerys AG
Cellerys AG Miscellaneous Commercial ServicesCommercial Services Engages in conducting research on a therapy to fight multiple sclerosis | Commercial Services |
